Maarten Knapen

Dr. Maarten Knapen


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Molecular Cytogenetics
Verified
Journal Article
Open access
PDF file
MSMalgorzata I Srebniak
Malgorzata I Srebniak
MBMarjan Boter
Marjan Boter
GOGretel O Oudesluijs
Gretel O Oudesluijs
TCTitia Cohen-Overbeek
Titia Cohen-Overbeek
LGLutgarde Cp Govaerts
Lutgarde Cp Govaerts
RGRobert-Jan H Galjaard
Robert-Jan H Galjaard
We have investigated whether replacing conventional karyotyping by SNP array analysis in cases of foetal ultrasound abnormalities would increase the diagnostic yield and speed of prenatal diagnosis in clinical practice.

7 September 2016 in Molecular Cytogenetics
Verified
Journal Article
Open access
PDF file
MSMalgorzata I. Srebniak
Malgorzata I. Srebniak
MWMerel C. de Wit
Merel C. de Wit
KDKarin E. M. Diderich
Karin E. M. Diderich
LGLutgarde C. P. Govaerts
Lutgarde C. P. Govaerts
MJMarieke Joosten
Marieke Joosten
DODiane Van Opstal
Diane Van Opstal
Since non-invasive prenatal testing (NIPT) in maternal blood became available, we evaluated which chromosome aberrations found in our cohort of fetuses with an enlarged NT in the first trimester of pregnancy (tested with SNP microarray) could be detected by NIPT as well. 362 fetuses were referred for cytogenetic testing due to an enlarged NT (≥3.5 mm). Chromosome aberrations were investigated using QF-PCR, karyotyping and whole genome SNP array. After invasive testing a chromosomal abnormality was detected in 137/362 (38 %) fetuses. 100/362 (28 %) cases concerned trisomy 21, 18 or 13, 25/362 (7 %) an aneuploidy of sex chromosomes and 3/362 (0.8 %) triploidy. In 6/362 (1.6 %) a pathogenic structural unbalanced chromosome aberration was seen and in 3/362 (0.8 %) a susceptibility locus for neurodevelopmental disorders was found. We estimated that in 2–10 % of fetuses with enlarged NT a chromosome aberration would be missed by current NIPT approaches. Based on our cohort of fetuses with enlarged NT we may conclude that NIPT, depending on the approach, will miss chromosome aberrations in a significant percentage of pregnancies. Moreover all abnormal NIPT results require confirmatory studies with invasive testing, which will delay definitive diagnosis in ca. 30 % of patients. These figures are important for pretest counseling enabling pregnant women to make informed choices on the prenatal test. Larger cohorts of fetuses with an enlarged NT should be investigated to assess the additional diagnostic value of high resolution array testing for this indication.

Verified
Journal Article
Open access
PDF file
SRSam Riedijk
Sam Riedijk
KDKarin E. M. Diderich
Karin E. M. Diderich
SSSanne L. Van der Steen
Sanne L. Van der Steen
LGLutgarde C. P. Govaerts
Lutgarde C. P. Govaerts
MJMarieke Joosten
Marieke Joosten
RGRobert-Jan H. Galjaard
Robert-Jan H. Galjaard
Pregnant couples tend to prefer a maximum of information about the health of their fetus. Therefore, we implemented whole genome microarray instead of conventional karyotyping (CK) for all indications for prenatal diagnosis (PND). The array detects more clinically relevant anomalies, including early onset disorders, not related to the indication and more genetic anomalies of yet unquantifiable risk, so-called susceptibility loci (SL) for mainly neurodevelopmental disorders. This manuscript highlights the psychological challenges in prenatal genetic counselling when using the array and provides counselling suggestions. First, we suggest that pre-test decision counselling should emphasize deliberation about what pregnant couples wish to learn about the future health of their fetus more than information about possible outcomes. Second, pregnant couples need support in dealing with SL. Therefore, in order to consider the SL in a proportionate perspective, the presence of phenotypes associated with SL in the family, the incidence of a particular SL in control populations and in postnatally ascertained patients needs highlighting during post-test genetic counselling. Finally, the decision that couples need to make about the course of their pregnancy is more complicated when the expected phenotype is variable and not quantifiable. Therefore, during post-test psychological counseling, couples should concretize the options of continuing and ending their pregnancy; all underlying feelings and thoughts should be made explicit, as well as the couple’s resources, in order to attain adequate decision-making. As such, pre- and post-test counselling aids pregnant couples in handling the uncertainties that may accompany offering a broader scope of genetic PND using the array.

5 March 2024 in Organoids
Verified
Journal Article
Open access
PDF file
BRBas van Rijn
Bas van Rijn
DODiane Van Opstal
Diane Van Opstal
NKNicole van Koetsveld
Nicole van Koetsveld
Maarten KnapenMaarten Knapen
Maarten Knapen
JGJoost Gribnau
Joost Gribnau
OSOlivier Schäffers
Olivier Schäffers
Studying human placental development and function presents significant challenges due to the inherent difficulties in obtaining and maintaining placental tissue throughout the course of an ongoing pregnancy. Here, we provide a detailed protocol for generating trophoblast organoids from chorionic villi obtained during ongoing pregnancy. Our method results in efficient generation of trophoblast organoids from chorionic villus sampling, does not require preselection of chorionic villi, and controls contamination of decidual gland organoids. The resulting trophoblast organoids spontaneously form syncytiotrophoblasts that start secreting hCG hormone amongst other placenta-specific factors. Our approach facilitates the generation of trophoblast organoids from a variety of genetic backgrounds, including trisomies and gene mutations, and can be aligned with prenatal diagnostic routines. The protocol requires up to 14 days and can be carried out by users with expertise in cell culture.

20 March 2013 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
FVFemke A.T. De Vries
Femke A.T. De Vries
LGLutgarde C.P. Govaerts
Lutgarde C.P. Govaerts
JKJeroen Knijnenburg
Jeroen Knijnenburg
Maarten KnapenMaarten Knapen
Maarten Knapen
GOGrétel G. Oudesluijs
Grétel G. Oudesluijs
DODiane Van Opstal
Diane Van Opstal

17 August 2015 in Prenatal Diagnosis
Verified
Journal Article
Open access
PDF file
CKCaroline C. Keller
Caroline C. Keller
MJMarieke Joosten
Marieke Joosten
AMAnnemieke M. Middeldorp
Annemieke M. Middeldorp
Maarten KnapenMaarten Knapen
Maarten Knapen
What's already known about this topic? The rare Guadalajara variant of G6PD deficiency is known for causing severe hemolytic anemia. What does this study add? This is the first published case of a diagnosed and treated fetal anemia, caused by the Guadalajara variant of G6PD deficiency. It is important to note that non‐invasive fetal Doppler screening can be performed for pregnant women who are carriers of this X‐linked recessive disorder.